Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04940000

Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)

Interventional, prospective, single-centre study aimed to evaluate the impact of a video-assisted remote speech therapy consultation in relation to the complexity and specificity of the care of patients with ORL cancer. Three indications will be studied: phonation problems, swallowing problems and other problems.

The study will be conducted on a population of patients with T3, T4 ORL cancer requiring speech therapy.

Each patient included will have a video-assisted speech therapy consultation with a private speech therapist and an expert speech therapist. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire.

At the follow-up visit following the video-assisted consultation, the patient will have completed participation in the study.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

ORL Cancer

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years at study entry.
  • Patient with carcinological pathology of the VADS, relevant to surgery and/or radiotherapy and/or chemotherapy.
  • Patient managed at the IUCT-O and by a private speech therapist (near the patient's home).
  • Patient affiliated to a Social Security system in France.
  • Patient having signed informed consent prior to inclusion in the study and prior to any specific study procedure.

Exclusion criteria

  • Pregnant or lactating women.
  • Any psychological, familial, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures foreseen in the study protocol.
  • Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).

Treatment and study plan

Patient managed at the IUCT-O and by a private speech therapist (near the patient's home).

Other

Each patient included will have a video-assisted remote speech therapy consultation with a private speech therapist (near the patient's home) and the expert speech therapist of IUCT-O center.

At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire.

Primary outcomes

  1. The rate of patients for whom tele-therapy will be considered successful.

    Time frame: 12 months for each patient

Secondary outcomes

  1. The rate of patients with full or partial resolution of speech-language pathology at the end of the telecare consultation.

    Time frame: 12 months for each patient

Study contacts

Contact information is provided by the study sponsor or research team.

Jean-Claude FARENC

CONTACT

[email protected]

05 31 15 51 97

Jérôme SARINI

CONTACT

[email protected]

05 31 15 60 16

Sponsors and collaborators

Lead sponsor

Institut Claudius Regaud

Other

Registry information

Important dates

Study start
2021
Primary completion
2028
Study completion
2028
First posted
Jun 25, 2021
Registry last updated
Jul 31, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.